Alignment Healthcare, Inc. Stock Price

high medical loss ratios, and negative free cash flow signal that scaling profitably remains elusive; further failures to contain medical costs as it expands geographically could force reliance on additional debt or equity financing, diluting future earnings per share. First ALHC has positive FCF Metric FY2023 FY2024 FY2025 Q1 2026 CapEx / revenue 2.0% 1.5% 0.7% 0.6% SEC FCF margin -5.2% -0.2% 2.9% 9.8% SBC / revenue 3.7% 2.6% 1.6% 1.1% Second it has AVA ALHC’s own filing describes AVA as the backbone of care delivery. It says AVA ingests longitudinal data from 200+ sources, provides real-time member assessments, delivers prescriptive insights, and guides workflows such as prescriptions, caregiver alerts, lab-to-doctor information transfer, and treatment planning. It also says AVA uses machine learning and AI to predict hospital admission / readmission risk, member satisfaction, disenrollment risk, and disease propensity scores. The “gets better with more data” argument is also supported. ALHC says AVA’s models are based on hundreds of thousands of historical outcomes and are constantly updated with new data sets, enabling them to get smarter and more effective. So yes, AVA has a potential data flywheel: More members → more claims / pharmacy / lab / care data → better risk prediction and care workflows → earlier interventions → lower avoidable utilization → better Stars / retention / MBR → stronger plan benefits and growth → more members That is why ALHC itself calls AVA a “significant competitive advantage” and says it helps deliver information-enabled healthcare at scale. ________________________________________ What AVA helps ALHC do better Business lever How AVA helps Why it matters Care management Finds high-risk members earlier and pushes action lists to care teams Can reduce admissions, readmissions, ER visits, and avoidable cost Provider workflows Gives providers utilization, care-gap, risk-assessment, and member-priority data